Hodgkin Lymphoma Classical

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-03-04
Clinical Trial Update: Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience
This clinical trial update reports real-world use of Brentuximab Vedotin with ABVD chemotherapy in untreated advanced-stage classical Hodgki…